Exosomes: Emerging roles in communication between blood cells and vascular tissues during atherosclerosis

Current Opinion in Lipidology

Volumn 26, Issue 5, 2015, Pages 412-419

  Huber, Heinrich J ^a,b   Holvoet, Paul ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Atherosclerosis; Blood mononuclear cells; Endothelial cells; Exosomes; Systems biology

Indexed keywords

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CELL; BLOOD CLOTTING; BLOOD VESSEL WALL; CELL COMMUNICATION; CELL MIGRATION; ENDOTHELIUM CELL; EXOSOME; HORIZONTAL GENE TRANSFER; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY; VASCULAR TISSUE; ANIMAL; METABOLISM; MICROVASCULATURE; OXIDATIVE STRESS; PARACRINE SIGNALING; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; ENDOTHELIAL CELLS; EXOSOMES; GENE TRANSFER, HORIZONTAL; HUMANS; MICROVESSELS; OXIDATIVE STRESS; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION;

EID: 84944348595     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000214     Document Type: Review

References (68)

1. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995; 57:791- 804.
2. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes 2003; 52:1799-1805.
3. Hirata Y, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011; 58:248-255.
4. Geeraert B, Crombe F, Hulsmans M, et al. Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulinresistant mice. Int J Obes (Lond) 2010; 34:569-577.
5. Hulsmans M, Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med 2010; 14:70-78.
6. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nature reviews. Immunology 2009; 9:581-593.
7. van der Pol E, Boing AN, Harrison P, et al. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacological reviews 2012; 64:676-705.
8. quadrito ML, et al. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep 2014; 8:1432-1446.
9. Villarroya-Beltri C, et al. Sorting it out: Regulation of exosome loading. Semin Cancer Biol 2014; 28:3-13.
10. de Jong OG, et al. Cellular stress conditions are reflected in the protein andRNA content of endothelial cell-derived exosomes. J Extracell Vesicles 2012; 1.
11. Melo SA, et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 2014; 26:707-721.
12. Hulsmans M, Holvoet P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 2013. doi: 10.1093/cvr/cvt1161.
13. Gallo A, et al. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012; 7:e30679.
14. Zomer A, et al. Exosomes: fit to deliver small RNA. Commun Integr Biol 2010; 3:44750.
15. Chevillet JR, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci U S A 2014; 111:14888-14893.
16. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic acids research 2012; 40: D1241-D1244.
17. Mathivanan S, Simpson RJ. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 2009; 9:4997-5000.
18. Baron M, Boulanger CM, Staels B, Tailleux A. Cell-derived microparticles in atherosclerosis: Biomarkers and targets for pharmacological modulation? Journal of cellular and molecular medicine 2012; 16:1365-1376.
19. Santovito D, et al. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: Effect of glycemic control. J Clin Endocrinol Metab 2014; 99:E1681-E1685.
20. Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 2007; 110:3234-3244.
21. Chaput N, Thery C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 2011; 33:419-440.
22. Bretz NP, Ridinger J, Rupp AK, et al. Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. The Journal of biological chemistry 2013; 288:36691-36702.
23. Hulsmans M, De Keyzer D, Holvoet P. MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 2011; 25:2515-2527.
24. Hulsmans M, Geeraert B, De KD, et al. Interleukin-1 receptor-Associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome. PLoS One 2012; 7:e30414.
25. Aharon A, Tamari T, Brenner B. Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost 2008; 100:878-885.
26. Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Molecular cell 2010; 39:133-144.
27. Lee HD, Kim YH, Kim DS. Exosomes derived from human macrophages suppress endothelial cell migration by controlling integrin trafficking. Eur J Immunol 2014; 44:1156-1169.
28. Liu ML, Scalia R, Mehta JL, Williams KJ. Cholesterol-induced membrane microvesicles as novel carriers of damage-Associated molecular patterns: mechanisms of formation, action, and detoxification. Arteriosclerosis, thrombosis, and vascular biology 2012; 32:2113-2121.
29. Zakharova L, Svetlova M, Fomina AF. T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J Cell Physiol 2007; 212:174-181.
30. Wahlgren J, De LKT, Brisslert M, et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic acids research 2012; 40:e130.
31. Janiszewski M, Do Carmo AO, Pedro MA, et al. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway. Critical care medicine 2004; 32:818-825.
32. Gambim MH, do Carmo Ade O, Marti L, et al. Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: Experimental evidence for a novel mechanism of septic vascular dysfunction. Crit Care 2007; 11:R107.
33. Danesh A, Inglis HC, Jackman RP, et al. Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood 2014; 123:687-696.
34. Alonso R, Mazzeo C, Rodriguez MC, et al. Diacylglycerol kinase alpha regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes. Cell death and differentiation 2011; 18:1161-1173.
35. Martinez-Lorenzo MJ, Anel A, Gamen S, et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. Journal of immunology 1999; 163:1274-1281.
36. Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 1999; 5:90-96.
37. Munich S, Sobo-Vujanovic A, Buchser WJ, et al. Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology 2012; 1:1074-1083.
38. Andreola G, Rivoltini L, Castelli C, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. The Journal of experimental medicine 2002; 195:1303-1316.
39. Deng ZB, Poliakov A, Hardy RW, et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 2009; 58:2498-2505.
40. Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyteendothelial cell interactions by platelet microparticles. The Journal of clinical investigation 1998; 102:136-144.
41. Kaneider NC, et al. CD40 ligand-dependent maturation of human monocytederived dendritic cells by activated platelets. Int J Immunopathol Pharmacol 2003; 16:225-231.
42. Weber A, Koppen HO, Schror K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 2000; 98:461-466.
43. Wang H, Wang ZH, Kong J, et al. Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress. Molecular medicine 2012; 18:159-166.
44. Heijnen HF, Schiel AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999; 94:3791-3799.
45. Gidlof O, van der Brug M, Ohman J, et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 2013; 121:3908-3917; S3901- 3926.
46. Srikanthan S, Li W, Silverstein RL, McIntyre TM. Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-Atherothombotic cellular functions, Journal of thrombosis and haemostasis : JTH. 2014; 12:1906-1917.
47. Al-Nedawi K, Szemraj J, Cierniewski CS. Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol 2005; 25:1744-1749.
48. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011; 31:27-33.
49. Jansen F, Yang X, Franklin BS, et al. High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. Cardiovascular research 2013; 98:94-106.
50. Liu ML, Williams KJ. Microvesicles: potential markers and mediators of endothelial dysfunction. Curr Opin Endocrinol Diabetes Obes 2012; 19: 121-127.
51. Wang Y, Chen LM, Liu ML. Microvesicles and diabetic complications - novel mediators, potential biomarkers and therapeutic targets. Acta Pharmacol Sin 2014; 35:433-443.
52. Pirro M, Schillaci G, Paltriccia R, et al. Increased ratio of CD31/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology 2006; 26:2530-2535.
53. Dursun I, Poyrazoglu HM, Gunduz Z, et al. The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 2009; 24:2511-2518.
54. Sheldon H, Heikamp E, Turley H, et al. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010; 116:2385-2394.
55. Liu ZJ, Tan Y, Beecham GW, et al. Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis. Atherosclerosis 2012; 225:296-303.
56. Quillard T, Devalliere J, Coupel S, Charreau B. Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. Biochemical pharmacology 2010; 80:2032- 2041.
57. Hansson GK, Libby P. The immune response in atherosclerosis: A doubleedged sword. Nat Rev Immunol 2006; 6:508-519.
58. Segura E, et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 2005; 106:216-223.
59. Angelot F, Seilles E, Biichle S, et al. Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica 2009; 94:1502-1512.
60. Kapustin AN, Chatrou ML, Drozdov I, et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circulation research 2015; 116:1312-1323.
61. Hergenreider E, Heydt S, Treguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature cell biology 2012; 14:249-256.
62. Peterson MF, Otoc N, Sethi JK, et al. Integrated systems for exosome investigation. Methods 2015. [Epub ahead of print].
63. Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Microfluidic device (Exo- Chip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab on a chip 2014; 14:1891-1900.
64. Verbruggen B, Leirs K, Puers R, Lammertyn J, Selective DNA. extraction with microparticles in segmented flow. Microfluid Nanofluid 2015; 18:293- 303.
65. Moltzahn F, Olshen AB, Baehner L, et al. Microfluidic-based multiplex qRTPCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer research 2011; 71:550-560.
66. Takahashi K, Yan IK, Kim C, et al. Analysis of extracellular RNA by digital PCR. Frontiers in oncology 2014; 4:129.
67. Gray WD, French KM, Ghosh-Choudhary S, et al. Identification of therapeutic covariant microRNA clusters in hypoxia-Treated cardiac progenitor cell exosomes using systems biology. Circulation research 2015; 116:255- 263.
68. Huber HJ, McKiernan RG, Prehn JH. Harnessing system models of cell death signalling for cytotoxic chemotherapy: Towards personalised medicine approaches? J Mol Med (Berl) 2014; 92:227-237.